Diaceutics Plc

Diaceutics (DXRX)

Buy
Sell
Company name:Diaceutics Plc
EPIC:DXRXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BJQTGV64
Market Segment:ASQ1Share Type:DE
WWW Address:www.diaceutics.comDescription:ORD GBP0.002
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 109.00 images.advfn.com/imagesnew/2/gb/down -5.5 [-4.80] 108.00 110.00 114.50 114.50 109.00 408,324
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 91.64 84.07 -0.04 0.34 - 320.59 - 191.00 - 99.50

Diaceutics Key Figures

(at previous day's close)
Market Cap.91.64m
Shares In Issue84.07m
Prev. Close114.50
PE Ratio320.59 
Dividend Yield-%
EPS - basic0.34p
Dividend PS-p
Dividend Cover- 
Cash Flow PS0.30p
Return On Equity (ROE)0.65%
Operating Margin-5.37%
PEG Factor-7.10 
EPS Growth Rate-45.16%
Dividends PS Growth Rate-%
Net Debt-21.97m
Gross Gearing7.54%
Quick Assets33.92m
Net Working Capital31.01m
Intangibles / Fixed Assets97.52%
Turnover PS15.10p
Pre-Tax Profit PS-0.81p
Retained Profit PS0.31p
Cash PS30.04p
Net Cash PS26.57p
Net Tangible Asset Value PS *36.73p
Net Asset Value PS47.86p
Spread2.00 (1.82%) 

Diaceutics Balance Sheet

L^DXRX:Liabilities+EQL^DXRX:Assets

Share Price Performance

Sample Period HighLow
1 week121.50109.00
4 weeks130.00109.00
12 weeks130.50109.00
1 year191.0099.50

Share Price Chart (5 years)

Diaceutics Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week121.50-12.50-10.29109.000.14116.67
4 weeks128.50-19.50-15.18109.000.10121.45
12 weeks125.50-16.50-13.15109.000.09124.03
26 weeks146.50-37.50-25.6099.500.07121.39
1 year167.50-58.50-34.9399.500.06127.80
3 years84.5024.5028.9978.000.05129.64
5 years84.5024.5028.9978.000.05129.64

Diaceutics Key Management Ratios

Diaceutics Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio92.25 
PE Ratio320.59 
Tobin's Q Ratio 2.78 
Tobin's Q Ratio (excl. intangibles)3.47 
Dividend Yield-%
Market-to-Book Ratio2.28 
Price-to-Pre-Tax Profit PS-134.36 
Price-to-Retained Profit PS348.42 
Price-to-Cash Flow PS362.19 
Price-to-Sales PS7.22 
Price-to-Net Tangible Asset Value PS2.97 
Price-to-Cash PS3.63 
Net Working Capital PS36.88 
Price Pct to Working Capital PS2.96%
Earnings Yield0.31%
Average PE278.58 
Years in average2 
PE to PE average115.08%

Diaceutics Financial Ratios

(Leverage Ratios)
Debt Ratio0.90%
Debt-to-Equity Ratio0.01 
Debt-to-Equity Ratio (excl. Intgbl)0.01 
Debt-to-Equity Market Value0.00 
Net Gearing-50.49%
Net Gearing (excl. Intangibles)-64.33%
Gross Gearing7.54%
Gross Gearing (excl. Intangibles)9.61%
Gearing Under 1 Year6.70%
Gearing Under 1 Year (excl. Intgbl)8.53%
Assets/Equity1.08 
Cash/Equity62.76 
(Liquidity Ratios)
Net Working Capital to Total Assets71.24%
Current Ratio11.64 
Quick Ratio (Acid Test)11.64 
Liquidity Ratio8.66 
Cash & Equiv/Current Assets74.45%
(Solvency Ratios)
Enterprise Value66.75m
CFO/Sales0.02 
CFO/Attributable Profit0.96 
CFO/Assets0.01 
CFO/Debt0.08 
Total Debt/Equity Market Value0.04 
Total Debt/Sales0.26 
Total Debt/Pre-Tax Profit-4.81 
Total Debt3.28m
Total Debt/Net Current Assets0.11%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)
-0.0424-0.0424

Diaceutics Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-1.68%
Return On Assets (ROA)0.80%
Net Profit Margin2.07%
Assets Turnover0.39 
Return On Equity (ROE)0.65%
Return On Investment (ROI)0.87%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio0.87%
Net Income Of Revenues2.07%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.42 
Fixed Assets Turnover1.88 
Current Assets Turnover0.48 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales2.59 
Debtors-to-Sales60.73%
Debt Collection Period221.68Days

Diaceutics Dividends

Sorry No Data Available

Diaceutics Fundamentals

 31 Dec 2019 (GBP)31 Dec 2020 (GBP)
turnover13.44100.00%12.70100.00%m
pre tax profit0.503.70%-0.68-5.37%m
attributable profit0.402.96%0.262.07%m
retained profit0.402.96%0.262.07%m
eps - basic (p)0.62 0.34 
eps - diluted (p)0.62 0.34 
dividends per share- - 

Diaceutics Balance Sheet

 31 Dec 2019 (GBP)31 Dec 2020 (GBP)
L^DXRX:Liabilities+EQL^DXRX:AssetsL^DXRX:Liabilities+EQL^DXRX:Assets
 31 Dec 2019 (GBP)31 Dec 2020 (GBP)
ASSETS
fixed assets fixed assets0.130.60%0.240.55%m
intangibles intangibles3.7616.81%9.3621.51%m
fixed investments fixed investments--%--%m
current assets - other current assets - other--%--%m
stocks stocks--%--%m
debtors debtors6.7630.20%8.6719.91%m
cash & securities cash & securities11.7252.39%25.2658.03%m
TOTAL22.37100%43.52100%m
LIABILITIES
creditors - short creditors - short2.2410.01%2.926.70%m
creditors - long creditors - long--%0.370.84%m
creditors - other creditors - other--%--%m
subordinated loans subordinated loans--%--%m
insurance funds insurance funds--%--%m
TOTAL2.2410.01%3.287.54%m
EQUITY
ord cap, reserves ord cap, reserves20.1389.99%40.2492.46%m
prefs, minorities prefs, minorities--%--%m
TOTAL20.1389.99%40.2492.46%m
OTHER
NAV Basic- - 
NAV Diluted- - 

Diaceutics Cash Flow Statement

31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF-0.630.25m
Pre-Financing CF-3.55-6.04m
Retained CF9.7413.57m

Diaceutics Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
DXRX
Diaceutics
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210725 21:33:47